Skip to content
Trending storyDeveloping

Microfluidic Platform Screens Three-Drug Ratios for Pediatric Leukemia in Three Days

1 report1 sourceupdated 8 hours ago

Start here

Synthesis

A microfluidic platform called GradientScreen, developed by Wilbur A. Lam's group at Georgia Institute of Technology and Emory University, screens three-drug combination ratios for pediatric acute lymphoblastic leukemia within three days. The device generates overlapping drug gradients and characterizes overall efficacy (Emax), potency synergy, and efficacy synergy of three-drug combinations in a ratio-dependent manner. Because it works with limited samples, the method can achieve stable ratio-defined three-drug exposure for drug response screening in relapsed or refractory patients. The platform has been demonstrated as reported; clinical adoption and validation in larger patient cohorts are still open questions.

Written by a model from the reports · updated 3 hours ago

Coverage timeline

Follow the coverage to see the different angles.

Oct 24
  1. mp.weixin.qq.com
    GradientScreen Microfluidic Platform Screens Three-Drug Ratios for Pediatric Acute Lymphoblastic Leukemia in Three Days

    The GradientScreen microfluidic platform, developed by Wilbur A. Lam's group at Georgia Institute of Technology and Emory University, screens three-drug combination ratios for pediatric acute lymphoblastic leukemia in three days. The platform uses a microfluidic device to generate overlapping drug gradients and characterizes overall efficacy (Emax), potency synergy, and efficacy synergy of three-drug combinations in a ratio-dependent manner. With limited samples, the method achieves stable ratio-defined three-drug exposure for drug response screening in relapsed or refractory patients.

Heat trend for this story

Heat now 8·Peak in the comparable set 10 (Oct 24 20:00)·Change over 24h in the comparable set –·Participants now 1

Participants counted1
00.250.50.751
Heat over time
02.557.510Oct24Oct24Oct25Oct25

Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org